Skip to content
  • Shop
    • Shop all
    • Devices
      • CAROL Bike
      • Agen Band
      • Agen Robot
      • Agen Smart Scale
      • Compare devices
    • Shop by goal
      • Heart
      • Mood & focus
      • Rest
      • Performance
      • Digestion
      • Skin & hair
      • Vitality
    • Bundles & plans
      • Daily longevity bundle
      • Executive focus kit
      • Peak recovery stack
      • Membership
  • App
  • How it works
  • Science
  • Journal
  • Partners

Language

  • Shop
    • Shop all
    • Devices
    • Shop by goal
    • Bundles & plans
  • App
  • How it works
  • Science
  • Journal
  • Partners
  • Country/Region

      No results found
    • Afghanistan AFN ؋
    • Åland Islands EUR €
    • Albania ALL L
    • Algeria DZD د.ج
    • Andorra EUR €
    • Angola USD $
    • Anguilla XCD $
    • Antigua & Barbuda XCD $
    • Argentina USD $
    • Armenia AMD դր.
    • Aruba AWG ƒ
    • Ascension Island SHP £
    • Australia AUD $
    • Austria EUR €
    • Azerbaijan AZN ₼
    • Bahamas BSD $
    • Bahrain USD $
    • Bangladesh BDT ৳
    • Barbados BBD $
    • Belarus USD $
    • Belgium EUR €
    • Belize BZD $
    • Benin XOF Fr
    • Bermuda USD $
    • Bhutan USD $
    • Bolivia BOB Bs.
    • Bosnia & Herzegovina BAM КМ
    • Botswana BWP P
    • Brazil USD $
    • British Indian Ocean Territory USD $
    • British Virgin Islands USD $
    • Brunei BND $
    • Bulgaria EUR €
    • Burkina Faso XOF Fr
    • Burundi BIF Fr
    • Cambodia KHR ៛
    • Cameroon XAF CFA
    • Canada CAD $
    • Cape Verde CVE $
    • Caribbean Netherlands USD $
    • Cayman Islands KYD $
    • Central African Republic XAF CFA
    • Chad XAF CFA
    • Chile USD $
    • China CNY ¥
    • Christmas Island AUD $
    • Cocos (Keeling) Islands AUD $
    • Colombia USD $
    • Comoros KMF Fr
    • Congo - Brazzaville XAF CFA
    • Congo - Kinshasa CDF Fr
    • Cook Islands NZD $
    • Costa Rica CRC ₡
    • Côte d’Ivoire XOF Fr
    • Croatia EUR €
    • Curaçao ANG ƒ
    • Cyprus EUR €
    • Czechia CZK Kč
    • Denmark DKK kr.
    • Djibouti DJF Fdj
    • Dominica XCD $
    • Dominican Republic DOP $
    • Ecuador USD $
    • Egypt EGP ج.م
    • El Salvador USD $
    • Equatorial Guinea XAF CFA
    • Eritrea USD $
    • Estonia EUR €
    • Eswatini USD $
    • Ethiopia ETB Br
    • Falkland Islands FKP £
    • Faroe Islands DKK kr.
    • Fiji FJD $
    • Finland EUR €
    • France EUR €
    • French Guiana EUR €
    • French Polynesia XPF Fr
    • French Southern Territories EUR €
    • Gabon XOF Fr
    • Gambia GMD D
    • Georgia USD $
    • Germany EUR €
    • Ghana USD $
    • Gibraltar GBP £
    • Greece EUR €
    • Greenland DKK kr.
    • Grenada XCD $
    • Guadeloupe EUR €
    • Guatemala GTQ Q
    • Guernsey GBP £
    • Guinea GNF Fr
    • Guinea-Bissau XOF Fr
    • Guyana GYD $
    • Haiti USD $
    • Honduras HNL L
    • Hong Kong SAR HKD $
    • Hungary HUF Ft
    • Iceland ISK kr
    • India INR ₹
    • Indonesia IDR Rp
    • Iraq USD $
    • Ireland EUR €
    • Isle of Man GBP £
    • Israel ILS ₪
    • Italy EUR €
    • Jamaica JMD $
    • Japan JPY ¥
    • Jersey USD $
    • Jordan USD $
    • Kazakhstan KZT ₸
    • Kenya KES KSh
    • Kiribati USD $
    • Kosovo EUR €
    • Kuwait USD $
    • Kyrgyzstan KGS som
    • Laos LAK ₭
    • Latvia EUR €
    • Lebanon LBP ل.ل
    • Lesotho USD $
    • Liberia USD $
    • Libya USD $
    • Liechtenstein CHF CHF
    • Lithuania EUR €
    • Luxembourg EUR €
    • Macao SAR MOP P
    • Madagascar USD $
    • Malawi MWK MK
    • Malaysia MYR RM
    • Maldives MVR MVR
    • Mali XOF Fr
    • Malta EUR €
    • Martinique EUR €
    • Mauritania USD $
    • Mauritius MUR ₨
    • Mayotte EUR €
    • Mexico USD $
    • Moldova MDL L
    • Monaco EUR €
    • Mongolia MNT ₮
    • Montenegro EUR €
    • Montserrat XCD $
    • Morocco MAD د.م.
    • Mozambique USD $
    • Myanmar (Burma) MMK K
    • Namibia USD $
    • Nauru AUD $
    • Nepal NPR Rs.
    • Netherlands EUR €
    • New Caledonia XPF Fr
    • New Zealand NZD $
    • Nicaragua NIO C$
    • Niger XOF Fr
    • Nigeria NGN ₦
    • Niue NZD $
    • Norfolk Island AUD $
    • North Macedonia MKD ден
    • Norway USD $
    • Oman USD $
    • Pakistan PKR ₨
    • Palestinian Territories ILS ₪
    • Panama USD $
    • Papua New Guinea PGK K
    • Paraguay PYG ₲
    • Peru PEN S/
    • Philippines PHP ₱
    • Pitcairn Islands NZD $
    • Poland PLN zł
    • Portugal EUR €
    • Qatar QAR ر.ق
    • Réunion EUR €
    • Romania RON Lei
    • Russia USD $
    • Rwanda RWF FRw
    • Samoa WST T
    • San Marino EUR €
    • São Tomé & Príncipe STD Db
    • Saudi Arabia SAR ر.س
    • Senegal XOF Fr
    • Serbia RSD РСД
    • Seychelles USD $
    • Sierra Leone SLL Le
    • Singapore SGD $
    • Sint Maarten ANG ƒ
    • Slovakia EUR €
    • Slovenia EUR €
    • Solomon Islands SBD $
    • Somalia USD $
    • South Africa USD $
    • South Georgia & South Sandwich Islands GBP £
    • South Korea KRW ₩
    • South Sudan USD $
    • Spain EUR €
    • Sri Lanka LKR ₨
    • St. Barthélemy EUR €
    • St. Helena SHP £
    • St. Kitts & Nevis XCD $
    • St. Lucia XCD $
    • St. Martin EUR €
    • St. Pierre & Miquelon EUR €
    • St. Vincent & Grenadines XCD $
    • Sudan USD $
    • Suriname USD $
    • Svalbard & Jan Mayen USD $
    • Sweden SEK kr
    • Switzerland CHF CHF
    • Taiwan TWD $
    • Tajikistan TJS ЅМ
    • Tanzania TZS Sh
    • Thailand THB ฿
    • Timor-Leste USD $
    • Togo XOF Fr
    • Tokelau NZD $
    • Tonga TOP T$
    • Trinidad & Tobago TTD $
    • Tristan da Cunha GBP £
    • Tunisia USD $
    • Türkiye USD $
    • Turkmenistan USD $
    • Turks & Caicos Islands USD $
    • Tuvalu AUD $
    • U.S. Outlying Islands USD $
    • Uganda UGX USh
    • Ukraine UAH ₴
    • United Arab Emirates AED د.إ
    • United Kingdom GBP £
    • United States USD $
    • Uruguay UYU $U
    • Uzbekistan UZS so'm
    • Vanuatu VUV Vt
    • Vatican City EUR €
    • Venezuela USD $
    • Vietnam VND ₫
    • Wallis & Futuna XPF Fr
    • Western Sahara MAD د.م.
    • Yemen YER ﷼
    • Zambia USD $
    • Zimbabwe USD $

    Language

    Language
    Account

    Your cart is empty

    Have an account? Log in to check out faster.

    Continue shopping

    ← Longevity & Supplement Guides

    How close to failure do you need to train?

    Training10 min read Sep 21, 2026Updated Sep 21, 2026

    Share

    A curve of bar speed falling across the repetitions of a set, with the final repetition marked in coral at the point of failure.

    In this guide

      Share

      There is a moment near the end of a hard set when the bar slows down and your face does something you would not want photographed. Gym culture has decided that moment is the point — that everything before it was rehearsal.

      It is a seductive idea, because effort is almost impossible to measure from the outside and failure is not. Failure is binary. You either finished the rep or the rep finished you. So it became the proxy for sincerity, and everything short of it became suspect: you left something in the tank, said in the tone reserved for moral lapses.

      The research of the last four years has quietly taken that idea apart — not by showing failure does nothing, but by pricing it. The last rep is real. It is also the most expensive thing you can buy in a gym, and for most of what most people want, it is optional.

      One person, two legs, eight weeks

      The cleanest experiment on this is also the strangest to picture. In 2024, Martin Refalo and colleagues at Deakin University took eighteen resistance-trained adults and randomised them against themselves. Each person's legs were assigned separately: one leg did the leg press and leg extension to momentary muscular failure, the other stopped with one to two repetitions in reserve. Twice a week, for eight weeks.

      The design is the whole point. When you compare two groups of people, you are also comparing their genetics, their sleep, their protein intake and their enthusiasm. When you compare someone's left quadriceps to their right, all of that cancels.

      Quadriceps thickness increased by about 0.18 cm on both sides. Not similar in the hand-waving sense — the same number to three decimal places, with the small remaining differences pointing in opposite directions depending on which muscle was measured.

      One detail is easy to skim past and shouldn't be. The failure leg consistently lost more repetitions from the first set to the last. It spent harder early and then had less to give, so across eight weeks the two legs ended up doing roughly the same total work. Failure did not add effort. It moved it.

      What happens when you pool the whole literature

      One clever trial is an anecdote with error bars. So here is the pooled picture, which is less flattering to both sides of the argument than either would like.

      Evidence

      Training to failure vs stopping short — pooled effect sizes, with 95% intervals

      ← FAVOURS STOPPING SHORT FAVOURS FAILURE → −0.4 −0.2 0 0.2 0.4 0.6 no difference Strength, failure vs non-failure Grgic 2022, 15 studies · ES −0.09 (−0.22 to 0.05) Muscle size, all adults Grgic 2022, 15 studies · ES 0.22 (−0.11 to 0.55) Muscle size, already-trained only Grgic 2022, subgroup · ES 0.15 (0.03 to 0.26) Muscle size, any definition of set failure Refalo 2023, 15 studies · ES 0.19 (0.00 to 0.37) Muscle size, true momentary failure only Refalo 2023, subgroup · ES 0.12 (−0.13 to 0.37) Muscle size, high vs moderate velocity loss Refalo 2023, subgroup · ES 0.08 (−0.16 to 0.32)
      interval clears zero interval touches zero interval includes zero
      Standardised effect sizes and 95% intervals exactly as published in Grgic et al., Journal of Sport and Health Science 2022 (15 studies) and Refalo et al., Sports Medicine 2023 (15 studies). Positions on the axis are the real values; a positive number favours training to failure. By convention an effect of about 0.2 is considered small.

      Read the plot from the top and the argument takes care of itself. For strength, the estimate sits slightly on the wrong side of zero. For muscle size across all adults, the point estimate looks encouraging and the interval is wide enough to drive a bus through. Only two estimates clear or graze zero, and both are small.

      The most telling row is the second from the bottom. When Refalo's team restricted the comparison to true momentary failure — not "a hard set", not "high velocity loss", but the rep that actually doesn't happen — the advantage vanished into the noise. The strictest test of the failure hypothesis is the one it passes least well.

      Strength and size don't want the same thing

      In 2024 a group led by Zac Robinson tried a better question. Instead of asking whether failure beats not-failure, they treated proximity to failure as a dial and asked what the dose–response curve looks like: 55 hypertrophy effects and 67 strength effects, regressed against estimated repetitions in reserve, adjusted for load, volume, study duration and training experience.

      The two outcomes came apart. For strength, the slope's confidence interval contained zero in every best-fitting model — gains were similar across a wide span of repetitions in reserve. For muscle size, the slope was negative and clear of zero: the closer sets ended to failure, the more growth.

      So the answer depends on what you are actually training for. If you lift to be strong — and if you are lifting for the next thirty years of your life, strength and the habit are what you are buying — the last rep appears to be nearly worthless. If you lift to add tissue, it buys something small and genuine.

      The authors are unusually honest about the limits, and it matters: the repetitions in reserve were estimated from how each study described its training, not measured. That is the best available shape of the curve, not the curve.

      What the last rep costs

      The benefit side of this ledger is small and contested. The cost side is not.

      A person sitting on the end of a weight bench between sets, forearms on knees, head lowered, catching their breath.
      The part of a hard set that no one photographs: the minutes afterwards, which is where the bill arrives.

      In July 2026, Nathan Cowley and colleagues ran eighteen lifters through a crossover study: back squats and prone rows, at 65% and 85% of one-rep max, stopping at failure, one rep in reserve, or three. Then they brought everyone back a day later and measured what was left.

      Neuromuscular fatigue, perceived fatigue and metabolic stress all rose as sets finished closer to failure, and the effect was still measurable twenty-four hours on. The surcharge also varied by lift: squats at the moderate load cost more than rows at the heavy one. Failure is not a flat fee. It is most expensive exactly where people most enjoy paying it — big compound lifts at weights that let you grind.

      Then there is the part nobody models. In a companion analysis of that same two-legs study, the failure protocol was rated as more uncomfortable, more effortful, and left people feeling measurably worse afterwards. Adherence is the most powerful training variable in existence, and failure quietly taxes it. A programme you resent is a programme you will eventually negotiate with.

      Nobody counts reps in reserve very well

      All of this rests on an assumption that deserves more scrutiny than it gets: that you know when you are two reps out.

      A 2025 trial from Brad Schoenfeld's lab — forty-two trained men and women doing a single set of nine exercises, twice a week for eight weeks, at failure or at two reps in reserve — tested that directly. Hypertrophy leaned slightly toward failure; strength and muscular endurance were the same either way. But the calibration result is the one worth keeping: people judged their reps in reserve far more accurately on the bench press than on the squat, and everyone got better at it over the eight weeks.

      Two reps in reserve is a skill, not a setting. On a lift you know intimately, your estimate is probably close. On a squat, or on anything new, "two left" can quietly mean five. This is also why the meta-analytic curve is drawn in pencil — if lifters can't judge proximity to failure precisely, neither can the papers describing them.

      Where to spend the failure budget

      Here is the practical shape of it. Treat failure as a currency you have a limited weekly amount of, and spend it where it is cheap.

      Applying it

      Three decisions, in the order they matter

      Most sets: stop with 1–3 reps in reserve
      This is where the pooled evidence actually sits, and it is not a compromise position — it is the condition that matched or beat failure on strength in every analysis above, and came within a small effect on size. You will also complete more quality repetitions across the session, because you are not spending the first set's currency on the third set's performance.
      If you spend it, spend it last and spend it safe
      The fatigue surcharge lands on everything that comes after, so a set taken to failure at the end of an exercise costs less than the same set at the beginning. Machines and single-joint movements are where failing is cheap and uncomplicated. A barbell squat at a grinding load is where it is most expensive — which is, inconveniently, where it feels most heroic.
      Calibrate with bar speed, not with feeling
      Perceived effort is a poor instrument near the end of a set; velocity is a better one. On most lifts, the first repetition that slows down visibly while your intent has not changed sits roughly one to two reps from failure. Pay attention to that rep for a few weeks and your estimates will sharpen — the trial above found exactly that improvement with practice.
      A reading of the evidence discussed above, not a prescription. Anyone with a medical condition or a recent injury should take programming advice from a qualified professional.

      The cost also shows up in places you can watch. Soreness is a poor guide on its own, but a week where every session ends in failure tends to announce itself in your morning numbers — a resting heart rate that drifts up, a heart-rate variability trend that sags. If you track those trends with the Agen Band, you are not looking for a verdict on today's session; you are looking for whether the last two weeks were affordable. That is also what a deload is for.

      Two footnotes for the over-forties, since that is where the stakes rise. The pooled subgroup that most clearly favoured failure was people who were already well trained — beginners had no such signal, which means the newest lifters have the least reason to grind. And if you are over 55 and lifting, one of the few supplement claims with authorised European standing is relevant here: creatine enhances the effect of resistance training on muscle strength in adults over 55, at 3 g per day.

      The bottom line

      Failure works. It just doesn't work much better than stopping a little short, it costs measurably more the next day, it makes training less pleasant to come back to, and the strictest version of the comparison shows the smallest benefit of all. If you lift for strength, the last rep is close to a rounding error. If you lift for size, it is worth a small amount and should be bought deliberately, at the end of an exercise, on a lift where failing is boring rather than dramatic.

      Which leaves the thing the research keeps implying without saying. The grind was never the mechanism. It was the part you could see — and, as usual, the visible thing got promoted to the important thing. Most of your sets should end while you still look composed. That is not holding back. That is what the evidence looks like when you stop reading it as a moral test.

      If you are assembling the rest of the picture, this sits inside the wider longevity protocol, alongside how you lower the weight and how to tell a hard week from a costly one.

      Sources

      1. Grgic J, Schoenfeld BJ, Orazem J, Sabol F. Effects of resistance training performed to repetition failure or non-failure on muscular strength and hypertrophy: a systematic review and meta-analysis. Journal of Sport and Health Science 2022;11(2):202-211. https://pubmed.ncbi.nlm.nih.gov/33497853/
      2. Refalo MC, Helms ER, Trexler ET, Hamilton DL, Fyfe JJ. Influence of resistance training proximity-to-failure on skeletal muscle hypertrophy: a systematic review with meta-analysis. Sports Medicine 2023;53(3):649-665. https://pubmed.ncbi.nlm.nih.gov/36334240/
      3. Refalo MC, Helms ER, Robinson ZP, Hamilton DL, Fyfe JJ. Similar muscle hypertrophy following eight weeks of resistance training to momentary muscular failure or with repetitions-in-reserve in resistance-trained individuals. Journal of Sports Sciences 2024;42(1):85-101. https://pubmed.ncbi.nlm.nih.gov/38393985/
      4. Robinson ZP, Pelland JC, Remmert JF, Refalo MC, Jukic I, Steele J, Zourdos MC. Exploring the dose-response relationship between estimated resistance training proximity to failure, strength gain, and muscle hypertrophy: a series of meta-regressions. Sports Medicine 2024;54(9):2209-2231. https://pubmed.ncbi.nlm.nih.gov/38970765/
      5. Cowley N, Refalo M, Nicholson V, Timmins R, Munteanu G, Weakley J. Effects of different resistance training loads, exercises, and volume-regulated proximities to failure on acute and short-term neuromuscular, perceptual, and metabolic responses. Journal of Sports Sciences 2026;44(14):1877-1896. https://pubmed.ncbi.nlm.nih.gov/42458937/
      6. Refalo MC, Helms ER, Hamilton DL, Fyfe JJ. The effect of proximity-to-failure on perceptual responses to resistance training. European Journal of Sport Science 2025;25(3):e12266. https://pubmed.ncbi.nlm.nih.gov/39960821/
      7. Hermann T, Mohan AE, Enes A, et al. Without fail: muscular adaptations in single-set resistance training performed to failure or with repetitions-in-reserve. Medicine & Science in Sports & Exercise 2025;57(9):2021-2031. https://pubmed.ncbi.nlm.nih.gov/40249908/
      8. EFSA Panel on Dietetic Products, Nutrition and Allergies. Creatine and muscle strength in adults over 55 years: scientific opinion. EFSA Journal 2016;14(2):4400. https://www.efsa.europa.eu/en/efsajournal/pub/4400

      About the author

      Vladimir Sitnikov is the founder of Agen. He writes about longevity, measurement, and building a wellbeing system that adapts to you.

      This article is for educational purposes only and is not medical advice. These statements have not been evaluated by the Food and Drug Administration. Agen products are not intended to diagnose, treat, cure, or prevent any disease. Consult your doctor before starting any supplement, especially if you are pregnant, nursing, or taking medication.

      Keep reading

      The Conductor’s Stairs: How a London Bus Gave Us the Idea of Exercise Training · 15 min read Creatine Without Exercise: Read the 1.1 kg Slowly Training · 9 min read Readiness scores: the most confident number on your wrist Recovery · 9 min read

      Keep your protocol honest.

      Every Agen supplement is evidence-scored the same way these guides are written. See what the science supports.

      Shop supplements
      Agen Com Pte Ltd

      Stay in control of your health and support your long-term wellness by uniting supplements, smart devices, and AI guidance into one system.

      Navigate

      • App
      • Robot
      • Band
      • CAROL Bike
      • Supplements
      • FAQ
      • Journal
      • Careers
      • Trust center
      • Contact us

      Information

      • Privacy Policy
      • Terms of Service
      • Shipping Policy
      • Return and Refund
      • Payment Policy
      • Warranty Policy

      Contacts

      Agen Com Pte. Ltd.

      8 Temasek Boulevard #30-01/02 Suntec Tower 3, Singapore 038988

      UEN: 202429937M

      support@agen.com

      +65 8422 1901

      These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. As with any dietary supplement, you should advise your healthcare practitioner of the use of this product.

      Payment methods
      • American Express
      • Apple Pay
      • Bizum
      • Google Pay
      • Mastercard
      • Shop Pay
      • Union Pay
      • Visa

      Copyright © 2026 Agen Com Pte. Ltd.

      Search

      Products

      • Agen Band
        Agen Band biomarker wearable, front view Agen Band biomarker wearable — supplement facts and ingredients

        Agen Band

        Regular price  $149.00 Sale price  $99.00
      • Agen Robot & Starter pack
        Agen Robot supplement dispenser on a kitchen counter Agen Robot supplement dispenser — supplement facts and ingredients

        Agen Robot & Starter pack

        $499.00
      • Agen Smart Scale
        Agen Scale, front view: 8-electrode body composition scale with handle bar and colour display Agen Scale, underside view: four sensor feet and handle bar dock

        Agen Smart Scale

        Regular price  $199.00 Sale price  $149.00
      • Ashwagandha
        Agen Ashwagandha supplement, front of bottle Agen Ashwagandha bottle on a travertine counter in soft morning light

        Ashwagandha

        $15.00

      You're in.

      Your 10% code is below — and on its way to your inbox.

      READY10
      Free shipping from $100 — $150 international

      10% off your first order

      Supplements dosed for your body — not the average. Free shipping from $100 — $150 international.

      Instant code · No spam · Unsubscribe anytime

      By signing up you agree to receive marketing emails. See our privacy policy and terms.